Trial Identifier: | D9673R00037 |
Sponsor: | AstraZeneca |
Start Date: | April 2024 |
Primary Completion Date: | May 2025 |
Study Completion Date: | May 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Argentina, ARGENTINA | Rosario, ARGENTINA, Argentina |
Brazil | Sao Paulo, Brazil |
Dominican Republic | Santo Domingo, Dominican Republic |
Hong Kong, Hong Kong | Hong Kong, Hong Kong |
India, Delhi | Delhi, India, 110085 |
India, Delhi | Delhi, India, 110005 |
India, Delhi | Delhi, India, 110029 |
India, Karnataka | Bengaluru, Karnataka, India, 560017 |
India, Kerala | Kochi, Kerala, India, 682041 |
India, Maharashtra | Mumbai, Maharashtra, India, 400012 |
India, Odisha | Bhubaneshwar, Odisha, India, 751003 |
India, Punjab | Mohali, Punjab, India, 160055 |
India, Telangana | Hyderabad, Telangana, India, 500034 |
India, Uttar Pradesh | Varanasi, Uttar Pradesh, India, 221005 |
Indonesia | Jakarta, Indonesia |
Malaysia | Kaula Lumpur, Malaysia, 47500 |
Malaysia | Subang Jaya, Malaysia, 47500 |
Malaysia | Subang Jaya, Malaysia, 59100 |
Mexico | Ciudad de Mexico, Mexico |
Panama | Panama, Panama |
Philippines | Quezon city, Philippines, 1112 |
Singapore | Singapore, Singapore, 229899 |
Singapore | Singapore, Singapore, 308433 |
Singapore | Singapore, Singapore, 168583 |
Singapore | Singapore, Singapore, 258499 |
Thailand | Bangkok, Thailand, 10700 |
Thailand | Bangkok, Thailand, 10400 |
Thailand | Bangkok, Thailand, 10330 |
Vietnam | Hanoi, Vietnam |
Vietnam | Ho Chi Minh, Vietnam |
Vietnam | Hue, Vietnam |